FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386564761> ?p ?o ?g. }

• W4386564761 abstract "Abstract Objectives Myocardial infarction (MI) initiates a complex reparative response during which damaged cardiac muscle is replaced by connective tissue. While the initial repair is essential for survival, excessive fibrosis post‐MI is a primary contributor to progressive cardiac dysfunction, and ultimately heart failure. Currently, there are no approved drugs for the prevention or the reversal of cardiac fibrosis. Therefore, we tested the therapeutic potential of repurposed mesalazine as a post‐MI therapy, as distinct antifibrotic effects have recently been demonstrated. Methods At 8 weeks of age, MI was induced in male C57BL/6J mice by LAD ligation. Mesalazine was administered orally at a dose of 100 μg/g body weight in drinking water. Fluid intake, weight development, and cardiac function were monitored for 28 days post intervention. Fibrosis parameters were assessed histologically and via qPCR. Results Compared to controls, mesalazine treatment offered no survival benefit. However, no adverse effects on heart and kidney function and weight development were observed, either. While total cardiac fibrosis remained largely unaffected by mesalazine treatment, we found a distinct reduction of perivascular fibrosis alongside reduced cardiac collagen expression. Conclusions Our findings warrant further studies on mesalazine as a potential add‐on therapy post‐MI, as perivascular fibrosis development was successfully prevented." @default.
• W4386564761 created "2023-09-10" @default.
• W4386564761 creator A5003703339 @default.
• W4386564761 creator A5028583008 @default.
• W4386564761 creator A5050149834 @default.
• W4386564761 creator A5053508004 @default.
• W4386564761 creator A5056423189 @default.
• W4386564761 creator A5059035028 @default.
• W4386564761 creator A5069089538 @default.
• W4386564761 creator A5072847905 @default.
• W4386564761 creator A5080288991 @default.
• W4386564761 creator A5089401859 @default.
• W4386564761 date "2023-09-01" @default.
• W4386564761 modified "2023-09-27" @default.
• W4386564761 title "Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice" @default.
• W4386564761 cites W1985644650 @default.
• W4386564761 cites W1993869526 @default.
• W4386564761 cites W1994553956 @default.
• W4386564761 cites W2020087937 @default.
• W4386564761 cites W2026222818 @default.
• W4386564761 cites W2037994205 @default.
• W4386564761 cites W2073419858 @default.
• W4386564761 cites W2075522000 @default.
• W4386564761 cites W2134890518 @default.
• W4386564761 cites W2139353011 @default.
• W4386564761 cites W2150529098 @default.
• W4386564761 cites W2167034393 @default.
• W4386564761 cites W2167279371 @default.
• W4386564761 cites W2168048360 @default.
• W4386564761 cites W2207494192 @default.
• W4386564761 cites W2228158706 @default.
• W4386564761 cites W2236258499 @default.
• W4386564761 cites W2259283850 @default.
• W4386564761 cites W2406508411 @default.
• W4386564761 cites W2427094903 @default.
• W4386564761 cites W2462759503 @default.
• W4386564761 cites W2608644283 @default.
• W4386564761 cites W2608650231 @default.
• W4386564761 cites W2750655551 @default.
• W4386564761 cites W2782006143 @default.
• W4386564761 cites W2799955645 @default.
• W4386564761 cites W2800350399 @default.
• W4386564761 cites W2801797179 @default.
• W4386564761 cites W2896002881 @default.
• W4386564761 cites W2955275838 @default.
• W4386564761 cites W2974204766 @default.
• W4386564761 cites W3043390187 @default.
• W4386564761 cites W3093386819 @default.
• W4386564761 cites W3110725520 @default.
• W4386564761 cites W3113178943 @default.
• W4386564761 cites W3193349356 @default.
• W4386564761 cites W3194188339 @default.
• W4386564761 cites W3194241696 @default.
• W4386564761 cites W4210607007 @default.
• W4386564761 cites W4312062859 @default.
• W4386564761 doi "https://doi.org/10.14814/phy2.15809" @default.
• W4386564761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37688424" @default.
• W4386564761 hasPublicationYear "2023" @default.
• W4386564761 type Work @default.
• W4386564761 citedByCount "0" @default.
• W4386564761 crossrefType "journal-article" @default.
• W4386564761 hasAuthorship W4386564761A5003703339 @default.
• W4386564761 hasAuthorship W4386564761A5028583008 @default.
• W4386564761 hasAuthorship W4386564761A5050149834 @default.
• W4386564761 hasAuthorship W4386564761A5053508004 @default.
• W4386564761 hasAuthorship W4386564761A5056423189 @default.
• W4386564761 hasAuthorship W4386564761A5059035028 @default.
• W4386564761 hasAuthorship W4386564761A5069089538 @default.
• W4386564761 hasAuthorship W4386564761A5072847905 @default.
• W4386564761 hasAuthorship W4386564761A5080288991 @default.
• W4386564761 hasAuthorship W4386564761A5089401859 @default.
• W4386564761 hasBestOaLocation W43865647611 @default.
• W4386564761 hasConcept C111566952 @default.
• W4386564761 hasConcept C126322002 @default.
• W4386564761 hasConcept C164705383 @default.
• W4386564761 hasConcept C197934379 @default.
• W4386564761 hasConcept C2777420927 @default.
• W4386564761 hasConcept C2778198053 @default.
• W4386564761 hasConcept C2779134260 @default.
• W4386564761 hasConcept C2779174533 @default.
• W4386564761 hasConcept C2780479503 @default.
• W4386564761 hasConcept C2780559512 @default.
• W4386564761 hasConcept C500558357 @default.
• W4386564761 hasConcept C71924100 @default.
• W4386564761 hasConcept C90924648 @default.
• W4386564761 hasConceptScore W4386564761C111566952 @default.
• W4386564761 hasConceptScore W4386564761C126322002 @default.
• W4386564761 hasConceptScore W4386564761C164705383 @default.
• W4386564761 hasConceptScore W4386564761C197934379 @default.
• W4386564761 hasConceptScore W4386564761C2777420927 @default.
• W4386564761 hasConceptScore W4386564761C2778198053 @default.
• W4386564761 hasConceptScore W4386564761C2779134260 @default.
• W4386564761 hasConceptScore W4386564761C2779174533 @default.
• W4386564761 hasConceptScore W4386564761C2780479503 @default.
• W4386564761 hasConceptScore W4386564761C2780559512 @default.
• W4386564761 hasConceptScore W4386564761C500558357 @default.
• W4386564761 hasConceptScore W4386564761C71924100 @default.
• W4386564761 hasConceptScore W4386564761C90924648 @default.
• W4386564761 hasIssue "17" @default.
• W4386564761 hasLocation W43865647611 @default.

• next